Apply an integrated approach towards patient care which links pharmaceutical science and pharmacy practice: 1,2,3,4,5,6,7Describe the concepts of health, illness, public health and the development of health policy, including the role of medicines in society: 1,2,3,4,5,6,7Describe the structure and function of healthcare provision in the UK, including the regulation of healthcare professionals: 1,2,3,4,5,6,7Recognise the key characteristics of a responsible and capable healthcare professional, including skills, attitudes and values: 1,2,3,4,5,6,7Describe the roles of other healthcare professionals and the importance of interprofessional collaboration: 1,2,3,4,5,6,7Demonstrate an understanding of the key features of the profession of pharmacy and the varied career profiles of pharmacists: 1,2,3,4,5,6,7Describe and apply the underpinning legal framework for the sale and supply of medicines in the UK: 1,2,3,4,5,6,7Demonstrate an ability to make sound and informed decisions in accordance with basic ethical principles: 1,2,3,4,5,6,7Describe the basic architecture and cellular diversity of prokaryotic and eukaryotic cells: 1,2,3,4,5,6,7Explain the essential aspects of metabolism at a cellular level: 1,2,3,4,5,6,7Describe the different types of inter- and intracellular signalling systems in eukaryotic cells: 1,2,3,4,5,6,7Describe the central role of thermodynamics, chemical kinetics and electrochemistry in biological systems: 1,2,3,4,5,6,7Describe the cellular and molecular interactions involved in the formation and function of tissues: 1,2,3,4,5,6,7Describe the role of genes in living organisms and how inheritance of genes affects human body systems: 1,2,3,4,5,6,7Describe the normal anatomy and physiology of the major body systems: 1,2,3,4,5,6,7Describe the structure and function of common receptor types: 1,2,3,4,5,6,7Interpret pharmacological data to identify drug-target interactions: 1,2,3,4,5,6,7Explain the common mechanisms by which drugs interact with physiological systems to exert pharmacological and adverse effects: 1,2,3,4,5,6,7Interpret common pathological symptoms associated with abnormal functions in body systems: 1,2,3,4,5,6,7Recognise and describe the structures and functions of molecules and their reactivity: 1,2,3,4,5,6,7Describe how functional groups affect the physicochemical properties of molecules: 1,2,3,4,5,6,7Describe how the physicochemical properties of molecules affect their formulation into medicines and the route of administration to patients: 1,2,3,4,5,6,7Describe why a variety of dosage forms is necessary and the relative merits and demerits of the available forms: 1,2,3,4,5,6,7Determine the purity and composition of compounds using appropriate practical and analytical techniques: 1,2,3,4,5,6,7Describe the process of drug design and development from identification of target to formulation: 1,2,3,4,5,6,7Describe and explain biopharmaceutics in terms of the relationship between dosage form and interaction of the drug substance with human physiology: 1,2,3,4,5,6,7Demonstrate a high level of laboratory skill and apply a knowledge of the skills necessary for the successful completion of appropriate manipulative practical exercises: 1,2,3,4,5,6,7Demonstrate competence in pharmaceutical calculations: 1,2,3,4,5,6,7Communicate complex concepts effectively, both orally and in writing in a manner, that reflects professional practice: 1,2,3,4,5,6,7
Practical skills assessmentThe assessment will comprise a variety of academic and professional skills-based tasks including essay(s), group work project(s) and presentation(s) undertaken over the three cycles of Stage 1 including formative opportunities.
Laboratory skills assessmentThe laboratory assessment component is comprised of:
- Chemistry experiments that include the synthesis of paracetamol (lab proforma: 10%) and the multi-step synthesis of CAPE (lab report: 60%)
- Pharmacology labs (KLE quizzes: 30%)
Cycle 1 examinationsThe end of cycle examination will comprise one paper in MCQ format. Formative tests will be provided prior to the examination to assist students with preparation. Low stakes summative assessments will be introduced to support student engagement with their studies. The low stakes assessments will be incorporated within this component and will comprise 5% of the overall mark. Examples may include MCQs, quizzes and other similar forms of assessment covering a variety of key topics from Cycle 1.
Cycle 2 examinationsThe end of cycle examination will comprise one paper in MCQ format. Low stakes summative assessments will be introduced to support student engagement with their studies. The low stakes assessments will be incorporated within this component and will comprise 5% of the overall mark. Examples may include MCQs, quizzes and other similar forms of assessment covering a variety of key topics from Cycle 2.
Cycle 3 examinationsThe end of cycle examination will comprise one paper in MCQ format. Low stakes summative assessments will be introduced to support student engagement with their studies. The low stakes assessments will be incorporated within this component and will comprise 5% of the overall mark. Examples may include MCQs, quizzes and other similar forms of assessment covering a variety of key topics from Cycle 3.
Professional skills developmentThe Professional Development assessment will include CPD activities, competency assessments (including calculations and communication skills), case studies in ethics, and evidence of professionalism measured by Professional Activity Credits.
End of year synoptic assessmentThis assessment will comprise both group work and individual assessment. It will potentially cover all topics studied during the year, but will focus in particular on demonstrating understanding of the integration of those topics.